UNFO Med Overview
UNFO Med is the developer of the Universal Neonatal Foot Orthotics (UNFO) device, a child-friendly corrective foot brace developed specifically for the effective, safe, and stress-free treatment of metatarsus adductus (MTA) in newborns. The UNFO brace addresses the difficulties and stress of frequent casting, the ineffectiveness of stretching, and the resulting under-treatment or over-treatment of MTA and clubfoot. UNFO has clients in Israel, Italy, Africa, Ukraine, and South Korea, and has received FDA approval in the United States and CE mark approval in Europe.
Latest News
growth-positive
Step by step: The Israeli who is helping toddlers walk
UNFO Med Ltd, a company founded by Dr. Eilon Daizade, aims to revolutionize the treatment of metatarsus adductus (MTA) in newborns. MTA is a common foot deformity in infants. The company has developed a lightweight and non-invasive product that corrects the problem without the need for casts or surgery. UNFO Meds product has gained approval from the FDA in the United States and the CE in Europe, and the company has clients in various countries. The CEO, Eilon Daizade, expresses the companys goal of helping infants worldwide and mentions the possibility of raising capital and exploring stock market options. The article also discusses the medical devices and computerization industry in Israel and its growing exports to countries like the United States and Asia.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 0 |
| Investors | 0 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | unfo-med.com |
| Careers | Careers page |
Locations
Haim Weizman St 52, Holon, Israel
Photos & Videos
3 item(s)
